Oncorena treatment for renal cancer
Oncorena has raised $14.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Oncorena's investors include HealthCap, Linc, Fåhraeus Startup and Growth, Partners for Development investments in Life Sciences.
Oncorena is headquartered in Lund, Sweden.
Oncorena treatment for renal cancer
Oncorena is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncorena — Funding & Investors." VCBacked, June 26, 2025, https://www.vcbacked.co/company/oncorena. Accessed September 30, 2026.
VCBacked. (2025). Oncorena — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/oncorena
{{cite web |title=Oncorena — Funding & Investors |url=https://www.vcbacked.co/company/oncorena |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated